Caribou Biosciences (CRBU) EPS (Basic) (2020 - 2026)
Caribou Biosciences (CRBU) posted quarterly EPS (Basic) of -$0.29 for Q1 2026, up 36.85% year-over-year from -$0.21 in Q1 2025, and up 5.28% quarter-over-quarter from -$0.31 in Q4 2025.
Caribou Biosciences (CRBU) EPS (Basic) (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has reported EPS (Basic) for 7 consecutive years, with -$0.29 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 36.85% year-over-year to -$0.29; the TTM figure through Mar 2026 stood at -$1.43 (up 38.61% YoY), while the FY2025 annual figure was -$1.59, up 3.92% from the prior year.
- EPS (Basic) advanced to -$0.29 in Q1 2026 per CRBU's latest filing, from -$0.31 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.29 in Q1 2026 and bottomed at -$1.25 in Q2 2022.
- Historically, EPS (Basic) has averaged -$0.61 across 5 years, with a median of -$0.51 in 2022.
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 72.96% — and 2024, when it sank 135.92%.
- Caribou Biosciences' EPS (Basic) stood at -$0.51 in 2022, then climbed by 0.41% to -$0.51 in 2023, then increased by 12.32% to -$0.45 in 2024, then jumped by 30.64% to -$0.31 in 2025, then grew by 5.28% to -$0.29 in 2026.
- Business Quant data shows CRBU's EPS (Basic) at -$0.29 in Q1 2026, -$0.31 in Q4 2025, and -$0.35 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Caribou Biosciences | 163.09 Mn | 50.78 Mn | - | -0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.26 |
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.31 |
| Sep 30, 2025 | -0.35 |
| Jun 30, 2025 | -0.51 |
| Mar 31, 2025 | -0.46 |
| Dec 31, 2024 | -0.45 |
| Sep 30, 2024 | -0.84 |
| Jun 30, 2024 | -0.63 |
| Mar 31, 2024 | -0.98 |
| Dec 31, 2023 | -0.51 |
| Sep 30, 2023 | -0.36 |
| Jun 30, 2023 | -1.25 |
| Mar 31, 2023 | -0.51 |
| Dec 31, 2022 | -0.51 |
| Sep 30, 2022 | -0.84 |
| Jun 30, 2022 | -1.25 |
| Mar 31, 2022 | -0.37 |
| Dec 31, 2021 | -0.58 |
| Sep 30, 2021 | -0.46 |